On July 12th, Gelonhui reported that an investor asked Shandong Head Group (002810.SZ) on the investor interaction platform, "Where will the company's future performance growth come from?" The company responded that the main growth points of the company's future performance are in plant capsules and pharmaceutical food-grade cellulose ether. In the first quarter of 2024, the gross profit ratio of the two will reach 76%.
山东赫达(002810.SZ)：未来业绩主要增长点在植物胶囊和医药食品级纤维素醚
Shandong Head Group (002810.SZ): The main growth points for future performance are plant capsules and pharmaceutical food-grade cellulose ether.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Hot News
Updated